ClinicalTrials.Veeva

Menu

Effectiveness of Computerized Device New of Visual Motor Simulation Versus Mirror Therapy in Hemiplegic Patients. (SI-VIM)

C

Centre Hospitalier Universitaire de Saint Etienne

Status

Completed

Conditions

Stroke

Treatments

Device: Intensive Visual Simulation 3 (IVS3) device
Device: Electroencephalography (EEG)
Device: traditional Mirror Therapy (TM)

Study type

Interventional

Funder types

Other

Identifiers

NCT04025411
2019-A00041-56 (Other Identifier)
18CH200

Details and patient eligibility

About

Mirror Therapy (TM) has been shown to be effective in motor rehabilitation of the hemiplegic upper limb, but its implementation in current clinical practice has several difficulties, both from the patient and physiotherapist point of view.

A new computerized Mirror Therapy (TM) device (Intensive Visual Simulation 3 (IVS3), Dessintey) which aims to solve the TM compliance problems and make it more efficient have been developed.

Full description

The aim of this study is to compare the observance and efficiency of the Intensive Visual Simulation 3 (IVS3) therapy as compared to traditional Mirror Therapy (TM) in a population of hemiplegic stroke patients.

Enrollment

37 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • First ischemic or hemorrhagic stroke for less than one year
  • Not having reoffend
  • Responsible for an initially complete hemiplegia,
  • Upper-limb deficiency with the modified Frenchay Score below 70,
  • Not neurological history other than stroke,
  • Having signed the written consent
  • Affiliated or entitled to a social security scheme

Exclusion criteria

  • Patient who have not Magnetic Resonance Images (MRI) of the brain during stroke
  • Having complete lesion of the primary motor cortex
  • With an addiction to alcohol or drugs
  • With psychiatric illness, cognitive impairment, uncontrolled disease / epilepsy, malignancy, severe renal or pulmonary impairment
  • History of associated disabling general disease
  • With associated cerebellar syndrome
  • With clinical involvement of the brainstem
  • Pregnancy in progress
  • Patients under the protection of justice.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

37 participants in 2 patient groups

Experimental group
Experimental group
Description:
Patient with stroke ischemic or hemorrhagic will be included. They will have visual motor simulation with the Intensive Visual Simulation 3 (IVS3) device and electroencephalography (EEG).
Treatment:
Device: Electroencephalography (EEG)
Device: Intensive Visual Simulation 3 (IVS3) device
Control group
Active Comparator group
Description:
Patient with stroke ischemic or hemorrhagic will be included. They will have simulation with the traditional Mirror Therapy (TM) and electroencephalography (EEG).
Treatment:
Device: Electroencephalography (EEG)
Device: traditional Mirror Therapy (TM)

Trial contacts and locations

1

Loading...

Central trial contact

Florence RANCON, CRA; Pascal GIRAUX, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems